Feasibility of myocardial perfusion assessment with contrast echocardiography: can it improve recognition of significant coronary artery disease in the ICU?


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
17 07 2019
Historique:
received: 19 02 2019
accepted: 18 06 2019
entrez: 19 7 2019
pubmed: 19 7 2019
medline: 30 1 2020
Statut: epublish

Résumé

Diagnosis of significant coronary artery disease (CAD) and acute coronary artery occlusion in ICU can be difficult, and an inappropriate intervention is potentially harmful. Myocardial contrast perfusion echo (MCPE) examines ultrasound contrast intensity replenishment curves in individual myocardial segments measuring peak contrast intensity and slope of return as an index of myocardial blood flow (units = intensity of ultrasound per second [dB/s]). MCPE could possibly serve as a triage tool to invasive angiography by estimating blood flow in the myocardium. We sought to assess feasibility in the critically ill and if MCPE could add incremental value to the clinical acumen in predicting significant CAD. This is a single-centre, prospective, observational study. Inclusion criteria were as follows: adult ICU patients with troponin I > 50 ng/L and cardiology referral being made for consideration of inpatient angiography. Exclusion criteria were as follows: poor echo windows (2 patients), known ischaemic heart disease, and contrast contraindications. Seven cardiologists and 6 intensivists blinded to outcome assessed medical history, ECG, troponin, and 2D echo images to estimate likelihood of significant CAD needing intervention (clinical acumen). Clinical acumen, quantitative MCPE, and subjective (visual) MCPE were assessed to predict significant CAD. Forty patients underwent MCPE analysis, 6 (15%) had significant CAD, and median 11 of 16 segments (IQR 8-13) could be imaged (68.8% [IQR 50-81]). No adverse events occurred. A significant difference was found in overall MCPE blood flow estimation between those diagnosed with significant CAD and those without (3.3 vs 2.4 dB/s, p = 0.050). A MCPE value of 2.8 dB/s had 67% sensitivity and 88% specificity in detecting significant CAD. Clinical acumen showed no association in prediction of CAD (OR 0.6, p = 0.09); however, if quantitative or visual MCPE analysis was included, a significant association occurred (OR 17.1, p = 0.01; OR 23.0, p = 0.01 respectively). MCPE is feasible in the critically ill and shows better association with predicting significant CAD vs clinical acumen alone. MCPE adds incremental value to initial assessment of the presence of significant CAD which may help guide those who require urgent angiography.

Sections du résumé

BACKGROUND
Diagnosis of significant coronary artery disease (CAD) and acute coronary artery occlusion in ICU can be difficult, and an inappropriate intervention is potentially harmful. Myocardial contrast perfusion echo (MCPE) examines ultrasound contrast intensity replenishment curves in individual myocardial segments measuring peak contrast intensity and slope of return as an index of myocardial blood flow (units = intensity of ultrasound per second [dB/s]). MCPE could possibly serve as a triage tool to invasive angiography by estimating blood flow in the myocardium. We sought to assess feasibility in the critically ill and if MCPE could add incremental value to the clinical acumen in predicting significant CAD.
METHODS
This is a single-centre, prospective, observational study. Inclusion criteria were as follows: adult ICU patients with troponin I > 50 ng/L and cardiology referral being made for consideration of inpatient angiography. Exclusion criteria were as follows: poor echo windows (2 patients), known ischaemic heart disease, and contrast contraindications. Seven cardiologists and 6 intensivists blinded to outcome assessed medical history, ECG, troponin, and 2D echo images to estimate likelihood of significant CAD needing intervention (clinical acumen). Clinical acumen, quantitative MCPE, and subjective (visual) MCPE were assessed to predict significant CAD.
RESULTS
Forty patients underwent MCPE analysis, 6 (15%) had significant CAD, and median 11 of 16 segments (IQR 8-13) could be imaged (68.8% [IQR 50-81]). No adverse events occurred. A significant difference was found in overall MCPE blood flow estimation between those diagnosed with significant CAD and those without (3.3 vs 2.4 dB/s, p = 0.050). A MCPE value of 2.8 dB/s had 67% sensitivity and 88% specificity in detecting significant CAD. Clinical acumen showed no association in prediction of CAD (OR 0.6, p = 0.09); however, if quantitative or visual MCPE analysis was included, a significant association occurred (OR 17.1, p = 0.01; OR 23.0, p = 0.01 respectively).
CONCLUSIONS
MCPE is feasible in the critically ill and shows better association with predicting significant CAD vs clinical acumen alone. MCPE adds incremental value to initial assessment of the presence of significant CAD which may help guide those who require urgent angiography.

Identifiants

pubmed: 31315648
doi: 10.1186/s13054-019-2519-1
pii: 10.1186/s13054-019-2519-1
pmc: PMC6635996
doi:

Substances chimiques

Contrast Media 0
Troponin I 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

257

Références

JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Cardiovasc Ultrasound. 2005 Jun 16;3:16
pubmed: 15958173
J Neurosurg. 2009 Nov;111(5):1023-8
pubmed: 19392602
Chest. 1991 Dec;100(6):1619-36
pubmed: 1959406
J Am Soc Echocardiogr. 2009 Nov;22(11):1249-55
pubmed: 19766449
J Crit Care. 2013 Aug;28(4):532.e11-7
pubmed: 23428709
J Am Coll Cardiol. 2013 Jun 18;61(24):2446-2455
pubmed: 23643501
Heart Lung Circ. 2013 Dec;22(12):996-1002
pubmed: 23764145
JACC Cardiovasc Imaging. 2014 Jan;7(1):40-8
pubmed: 24290568
Crit Care. 2014 Jul 11;18(4):R149
pubmed: 25015102
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Heart. 2015 Apr;101(7):559-64
pubmed: 25608747
J Am Soc Echocardiogr. 2015 Feb;28(2):183-93
pubmed: 25623220
Prog Cardiovasc Dis. 2015 May-Jun;57(6):632-43
pubmed: 25817740
Crit Care. 2016 Mar 15;20:58
pubmed: 26976127
Anaesth Intensive Care. 2016 Sep;44(5):542-51
pubmed: 27608336
Clin Cardiol. 2017 Sep;40(9):679-685
pubmed: 28430369
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592
Circulation. 1998 Feb 10;97(5):473-83
pubmed: 9490243

Auteurs

Sam Orde (S)

Intensive Care Unit, Nepean Hospital, Sydney, 2750, Australia. sam.orde@health.nsw.gov.au.
Intensive Care Unit, Nepean Hospital, Kingswood, Sydney, NSW, 2749, Australia. sam.orde@health.nsw.gov.au.

Michel Slama (M)

Medical ICU, Amiens University Hospital, Amiens, France.

Faraz Pathan (F)

Cardiology Department, Nepean Hospital, Sydney, 2750, Australia.

Stephen Huang (S)

Intensive Care Unit, Nepean Hospital, Sydney, 2750, Australia.

Anthony Mclean (A)

Intensive Care Unit, Nepean Hospital, Sydney, 2750, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH